Ethelred E Carter, MD
Internal Medicine · Los Angeles
- Medicare standing
- 2 flags on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 58 years
- Graduated 1968
On the public record
- California licence: Accusation Filed
- 1 Medical Board action on record
Offices
2 locations
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Carter’s office at (323) 260-7252 to ask if they take your plan before you enroll.
California Medical Board record
Licence A29534 · Current
Licensed to practise in California · since 1975 · expires 2028-03-31 · Autonomous University of Guadalajara Faculty of Medicine. Board flags: Accusation Filed.
Public record actions
| 2026-09-09 | Board disciplineDiscipline | Accusation filed. the physician has not had a hearing or been found guilty of any charges. · 8002025120340 |
Original Medicare doctor bills
$41,915
Medicare paid this office $41,915 for 166 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 53 | $6,812 | $129 |
| Diagnostic exam of large bowel using a flexible endoscope | 45 | $6,727 | $149 |
| Insertion of stomach feeding tube | 11 | $6,394 | $581 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 65 | $5,801 | $87 |
| Return visit (30+ min) | 17 | $2,089 | $104 |
See all 8 services
| New patient visit (45+ min) | 53 | $6,812 | $129 |
| Diagnostic exam of large bowel using a flexible endoscope | 45 | $6,727 | $149 |
| Insertion of stomach feeding tube | 11 | $6,394 | $581 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 65 | $5,801 | $87 |
| Return visit (30+ min) | 17 | $2,089 | $104 |
| Biopsy of large bowel using a flexible endoscope | 12 | $1,969 | $164 |
| Short return visit (20+ min) | 20 | $1,760 | $77 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,064 | $82 |
Procedures Medicare counted
| Colonoscopy | 13 | More than 43% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 33 | More than 57% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 131 | 101 | 119 | 93 | 52 | 67 |
| Diagnostic exam of large bowel using a flexible endoscope | 81 | 61 | 80 | 39 | 40 | 45 |
| Biopsy of large bowel using a flexible endoscope | 31 | 18 | 19 | 17 | 11 | 12 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 28 | 11 | 20 | – | – | 13 |
| Insertion of stomach feeding tube | 13 | 14 | 23 | – | – | 11 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | – | – | 12 | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
166 Original Medicare patients in 2024. Average age 72 · Under 65 16% · 85 and older 14% · Women 64% · Health risk score 2.56. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 70% · Coronary heart disease 43% · Chronic kidney disease 40% · Heart failure 37% · Depression 31% · Dementia 25% · Atrial fibrillation 24% · COPD 19% · Stroke 18% · Cancer 17%.
The office billed $217,970, Medicare allowed $53,801 and paid $41,915; for 290 services of 26 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 166 | 290 | 72 | 2.56 | $217,970 | $41,915 |
| 2023 | 135 | 222 | 72 | 2.78 | $154,180 | $29,972 |
| 2022 | 142 | 307 | 73 | 2.67 | $192,905 | $36,370 |
| 2021 | 233 | 481 | 73 | 2.92 | $342,755 | $70,760 |
| 2020 | 187 | 342 | 72 | 3.21 | $264,895 | $49,541 |
| 2019 | 270 | 546 | 71 | 3.22 | $366,600 | $70,086 |
| 2018 | 241 | 450 | 72 | 2.96 | $298,400 | $52,669 |
| 2017 | 255 | 484 | 71 | 2.79 | $297,250 | $57,944 |
| 2016 | 290 | 560 | 72 | 2.62 | $337,205 | $67,133 |
| 2015 | 382 | 832 | 72 | 3.30 | $530,775 | $101,871 |
| 2014 | 412 | 925 | 72 | 3.02 | $632,285 | $116,549 |
| 2013 | 440 | 852 | 72 | 2.52 | $537,080 | $107,302 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| New patient visit (45+ min) | 47 | $6,412 | $136 |
| Diagnostic exam of large bowel using a flexible endoscope | 39 | $6,135 | $153 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 50 | $4,212 | $81 |
| Return visit (30+ min) | 22 | $2,449 | $106 |
| Biopsy of large bowel using a flexible endoscope | 11 | $1,835 | $167 |
2022: 6 services
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 84 | $8,066 | $87 |
| New patient visit (45+ min) | 46 | $6,216 | $135 |
| Diagnostic exam of large bowel using a flexible endoscope | 39 | $6,158 | $158 |
| Return visit (30+ min) | 27 | $3,256 | $109 |
| Short return visit (20+ min) | 33 | $3,108 | $78 |
| Biopsy of large bowel using a flexible endoscope | 17 | $2,921 | $172 |
2021: 9 services
| Insertion of stomach feeding tube | 23 | $14,148 | $615 |
| Diagnostic exam of large bowel using a flexible endoscope | 75 | $12,862 | $161 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 112 | $10,604 | $89 |
| New patient visit (45+ min) | 58 | $8,565 | $148 |
| Return visit (30+ min) | 40 | $5,582 | $107 |
| Short return visit (20+ min) | 42 | $3,489 | $78 |
| Biopsy of large bowel using a flexible endoscope | 19 | $3,145 | $166 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 11 | $2,643 | $220 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | $1,815 | $91 |
2020: 8 services
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 94 | $9,817 | $97 |
| Diagnostic exam of large bowel using a flexible endoscope | 58 | $9,757 | $160 |
| Insertion of stomach feeding tube | 14 | $8,613 | $615 |
| New patient visit (45+ min) | 36 | $4,799 | $133 |
| Biopsy of large bowel using a flexible endoscope | 18 | $3,175 | $176 |
| Return visit (30+ min) | 20 | $1,725 | $82 |
| Short return visit (20+ min) | 20 | $1,261 | $60 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,137 | $103 |
2019: 8 services
| Diagnostic exam of large bowel using a flexible endoscope | 78 | $13,007 | $161 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 126 | $11,569 | $88 |
| New patient visit (45+ min) | 72 | $9,230 | $128 |
| Insertion of stomach feeding tube | 13 | $7,810 | $601 |
| Return visit (30+ min) | 53 | $5,432 | $91 |
| Biopsy of large bowel using a flexible endoscope | 31 | $5,357 | $173 |
| Short return visit (20+ min) | 54 | $4,078 | $62 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 26 | $2,473 | $88 |
2018: 8 services
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 112 | $10,475 | $87 |
| Diagnostic exam of large bowel using a flexible endoscope | 61 | $9,543 | $151 |
| New patient visit (45+ min) | 47 | $5,900 | $126 |
| Return visit (30+ min) | 43 | $3,984 | $89 |
| Short return visit (20+ min) | 52 | $3,608 | $58 |
| Biopsy of large bowel using a flexible endoscope | 21 | $3,491 | $166 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | $1,732 | $87 |
| Change of stomach feeding, accessed through the skin | 16 | $622 | $37 |
2017: 7 services
| New patient visit (45+ min) | 92 | $11,772 | $128 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 92 | $8,980 | $93 |
| Diagnostic exam of large bowel using a flexible endoscope | 45 | $7,900 | $152 |
| Short return visit (20+ min) | 76 | $5,145 | $56 |
| Biopsy of large bowel using a flexible endoscope | 20 | $3,273 | $164 |
| Return visit (30+ min) | 25 | $2,185 | $84 |
| Change of stomach feeding, accessed through the skin | 18 | $801 | $38 |
2016: 10 services
| New patient visit (45+ min) | 81 | $10,818 | $134 |
| Diagnostic exam of large bowel using a flexible endoscope | 58 | $9,614 | $158 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 101 | $9,574 | $88 |
| Insertion of stomach feeding tube | 14 | $8,341 | $596 |
| Short return visit (20+ min) | 79 | $6,458 | $60 |
| Biopsy of large bowel using a flexible endoscope | 29 | $5,076 | $175 |
| Return visit (30+ min) | 29 | $2,549 | $88 |
| New patient visit (30+ min) | 21 | $1,673 | $80 |
| Change of stomach feeding, accessed through the skin | 15 | $675 | $36 |
| Short return visit | 18 | $669 | $35 |
2015: 14 services
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 163 | $16,980 | $96 |
| Diagnostic exam of large bowel using a flexible endoscope | 92 | $14,573 | $152 |
| Insertion of stomach feeding tube | 24 | $14,078 | $587 |
| Biopsy of large bowel using a flexible endoscope | 48 | $10,468 | $214 |
| New patient visit (45+ min) | 40 | $5,454 | $136 |
| Short return visit (20+ min) | 73 | $5,233 | $58 |
| New patient visit (30+ min) | 53 | $4,309 | $81 |
| Short return visit | 72 | $3,685 | $36 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $1,705 | $155 |
| Change of stomach feeding, accessed through the skin | 27 | $1,329 | $40 |
| Return visit (30+ min) | 14 | $1,188 | $85 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,180 | $84 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,133 | $103 |
| Diagnostic exam of lower portion of large bowel using a flexible endoscope | 16 | $790 | $46 |
2014: 14 services
| Diagnostic exam of large bowel using a flexible endoscope | 108 | $18,902 | $169 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 191 | $18,346 | $92 |
| Insertion of stomach feeding tube | 24 | $13,844 | $577 |
| Biopsy of large bowel using a flexible endoscope | 59 | $13,522 | $215 |
| Insertion of stent into pancreatic or bile duct using a flexible endoscope | 14 | $6,054 | $404 |
| New patient visit (45+ min) | 41 | $5,304 | $129 |
| Short return visit (20+ min) | 66 | $4,207 | $57 |
| Short return visit | 81 | $3,842 | $35 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 32 | $3,543 | $98 |
| New patient visit (30+ min) | 41 | $3,343 | $82 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 12 | $3,058 | $255 |
| Return visit (30+ min) | 32 | $2,631 | $80 |
| Change of stomach feeding, accessed through the skin | 23 | $1,123 | $39 |
| Diagnostic exam of lower portion of large bowel using a flexible endoscope | 13 | $586 | $45 |
2013: 16 services
| Diagnostic exam of large bowel using a flexible endoscope | 97 | $17,240 | $176 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 157 | $16,737 | $101 |
| Insertion of stomach feeding tube | 24 | $13,483 | $562 |
| Biopsy of large bowel using a flexible endoscope | 45 | $9,907 | $211 |
| New patient visit (30+ min) | 73 | $6,308 | $86 |
| New patient visit (45+ min) | 43 | $5,692 | $132 |
| Insertion of tube or stent into bile or pancreatic duct using an endoscope | 14 | $5,278 | $352 |
| Short return visit (20+ min) | 66 | $4,464 | $60 |
| Short return visit | 84 | $3,724 | $37 |
| Return visit (30+ min) | 39 | $3,360 | $86 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 13 | $3,261 | $251 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 29 | $3,075 | $93 |
| Incision of pancreatic outlet using a flexible endoscope | 14 | $1,394 | $82 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,103 | $79 |
| Change of stomach feeding, accessed through the skin | 18 | $806 | $38 |
| Diagnostic exam of lower portion of large bowel using a flexible endoscope | 14 | $771 | $45 |
Medicaid work
$184,277 in 2024
Medicaid paid $184,277 for 2,450 billed services this clinician did in 2024, up to 47 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Upper gastrointestinal endoscopy with biopsy | 466 | $50,549 |
| DIAGNOSTIC COLONOSCOPY | 279 | $45,981 |
| Service | 205 | $31,484 |
| New patient visit (45+ min) | 297 | $20,984 |
| New patient visit (30+ min) | 336 | $16,719 |
| Short return visit (20+ min) | 263 | $6,117 |
| TISSUE EXAM BY PATHOLOGIST | 172 | $4,333 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 154 | $3,112 |
| Service | 89 | $2,923 |
| Special stain including interpretation and report; Group II, all other (eg, iron, trichrome), except stain for microorganisms, stains for enzyme constituents, or immunocytochemistry and immunohistochemistry | 130 | $1,210 |
| Moderate sedation services provided by a physician or other qualified health care professional other than the physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports; initial 15 minutes of intraservice time, patient age 5 years or older | 15 | $865 |
| Supplies and materials (except spectacles), provided by the physician or other qualified health care professional over and above those usually included with the office visit or other services rendered (list drugs, trays, supplies, or materials provided) | 44 | $0 |
| 2024 | 2,450 | 12 | 47 | $184,277 |
| 2023 | 3,093 | 14 | 58 | $293,822 |
| 2022 | 1,585 | 10 | 53 | $119,094 |
| 2021 | 1,033 | 13 | 25 | $49,963 |
| 2020 | 575 | 6 | 42 | $35,523 |
| 2019 | 860 | 9 | 35 | $49,967 |
| 2018 | 703 | 10 | 24 | $30,377 |
See the largest Medicaid services in earlier years
2023
| DIAGNOSTIC COLONOSCOPY | 395 | $83,259 |
| Upper gastrointestinal endoscopy with biopsy | 562 | $74,501 |
| New patient visit (45+ min) | 516 | $40,026 |
| Service | 210 | $39,086 |
| New patient visit (30+ min) | 509 | $25,183 |
| TISSUE EXAM BY PATHOLOGIST | 204 | $10,990 |
| Short return visit (20+ min) | 281 | $6,593 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 164 | $6,425 |
| Special stain including interpretation and report; Group II, all other (eg, iron, trichrome), except stain for microorganisms, stains for enzyme constituents, or immunocytochemistry and immunohistochemistry | 145 | $2,972 |
| Supplies and materials (except spectacles), provided by the physician or other qualified health care professional over and above those usually included with the office visit or other services rendered (list drugs, trays, supplies, or materials provided) | 21 | $2,850 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 19 | $1,110 |
| Service | 16 | $512 |
2022
| Upper gastrointestinal endoscopy with biopsy | 329 | $40,800 |
| DIAGNOSTIC COLONOSCOPY | 188 | $38,526 |
| New patient visit (30+ min) | 458 | $17,263 |
| New patient visit (45+ min) | 223 | $14,609 |
| Short return visit (20+ min) | 207 | $3,739 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 29 | $1,734 |
| TISSUE EXAM BY PATHOLOGIST | 51 | $991 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 40 | $731 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 26 | $378 |
| Special stain including interpretation and report; Group II, all other (eg, iron, trichrome), except stain for microorganisms, stains for enzyme constituents, or immunocytochemistry and immunohistochemistry | 34 | $323 |
2021
| DIAGNOSTIC COLONOSCOPY | 134 | $15,749 |
| Upper gastrointestinal endoscopy with biopsy | 200 | $13,637 |
| Service | 32 | $5,759 |
| New patient visit (30+ min) | 221 | $4,355 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 56 | $4,317 |
| Short return visit (20+ min) | 143 | $1,780 |
| Injection, propofol, 10 mg | 26 | $1,228 |
| TISSUE EXAM BY PATHOLOGIST | 68 | $1,224 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 44 | $621 |
| New patient visit (45+ min) | 12 | $551 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 57 | $423 |
| Special stain including interpretation and report; Group II, all other (eg, iron, trichrome), except stain for microorganisms, stains for enzyme constituents, or immunocytochemistry and immunohistochemistry | 28 | $246 |
2020
| Upper gastrointestinal endoscopy with biopsy | 140 | $14,591 |
| DIAGNOSTIC COLONOSCOPY | 78 | $12,539 |
| New patient visit (30+ min) | 242 | $6,625 |
| Short return visit (20+ min) | 91 | $1,090 |
| New patient visit (45+ min) | 12 | $631 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 12 | $47 |
2019
| Upper gastrointestinal endoscopy with biopsy | 269 | $23,705 |
| DIAGNOSTIC COLONOSCOPY | 121 | $14,442 |
| New patient visit (30+ min) | 280 | $6,426 |
| Service | 14 | $2,618 |
| Short return visit (20+ min) | 106 | $1,238 |
| New patient visit (45+ min) | 28 | $1,049 |
| TISSUE EXAM BY PATHOLOGIST | 17 | $247 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 13 | $172 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 12 | $70 |
2018
| Service | 72 | $12,929 |
| Upper gastrointestinal endoscopy with biopsy | 169 | $9,817 |
| DIAGNOSTIC COLONOSCOPY | 69 | $2,426 |
| New patient visit (30+ min) | 176 | $1,758 |
| TISSUE EXAM BY PATHOLOGIST | 50 | $1,326 |
| Injection, propofol, 10 mg | 26 | $942 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 13 | $349 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 45 | $299 |
| Special stain including interpretation and report; Group II, all other (eg, iron, trichrome), except stain for microorganisms, stains for enzyme constituents, or immunocytochemistry and immunohistochemistry | 13 | $272 |
| Short return visit (20+ min) | 70 | $259 |
Drugs they prescribed that Part D paid
$26,270
Pharmacies billed $26,270 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 746) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
685 generic and 61 brand-name prescriptions · $26,270 in drug cost · 44 antibiotic prescriptions to 26 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Linzess | 17 | $8,916 | $524 |
| Gavilyte-G | 107 | $1,630 | $15 |
| Omeprazole | 198 | $1,094 | $6 |
| Metoprolol | 21 | $794 | $38 |
| Sucralfate | 53 | $719 | $14 |
See all 14 drugs
| Linzess | 17 | $8,916 | $524 |
| Gavilyte-G | 107 | $1,630 | $15 |
| Omeprazole | 198 | $1,094 | $6 |
| Metoprolol | 21 | $794 | $38 |
| Sucralfate | 53 | $719 | $14 |
| Metoclopramide | 103 | $649 | $6 |
| Peg-3350 and Electrolytes | 32 | $472 | $15 |
| Metronidazole | 22 | $188 | $9 |
| Gavilyte-C | 12 | $187 | $16 |
| Gabapentin | 13 | $164 | $13 |
| Ramipril | 12 | $114 | $10 |
| Famotidine | 23 | $94 | $4 |
| Temazepam | 12 | $40 | $3 |
| Meloxicam | 12 | $17 | $1 |
Year by year
| 2024 | 746 | 237 | 0% (0) | 8% | $26,270 |
| 2023 | 799 | 243 | 0% (0) | None | $63,914 |
| 2022 | 896 | 247 | 0% (0) | 18% | $65,265 |
| 2021 | 693 | 155 | 0% (0) | 18% | $55,243 |
| 2020 | 734 | 156 | 0% (0) | 13% | $64,428 |
| 2019 | 848 | 233 | 0% (0) | 14% | $57,409 |
| 2018 | 885 | 224 | 0% (0) | 14% | $58,952 |
| 2017 | 1,151 | 314 | 0% (0) | 19% | $58,580 |
| 2016 | 1,242 | 289 | 0% (0) | 23% | $80,871 |
| 2015 | 1,200 | 241 | 0% (0) | 29% | $117,024 |
| 2014 | 1,037 | 268 | None | 26% | $72,343 |
| 2013 | 1,353 | 308 | None | None | $71,374 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Linzess | 37 | $20,488 | $554 |
| Creon | 14 | $15,319 | $1,094 |
| Omeprazole | 194 | $2,476 | $13 |
| Sucralfate | 84 | $2,091 | $25 |
| Gavilyte-G | 106 | $1,806 | $17 |
| Metoclopramide | 120 | $1,572 | $13 |
| Metoprolol | 14 | $617 | $44 |
| Peg-3350 and Electrolytes | 29 | $466 | $16 |
| Metronidazole | 25 | $405 | $16 |
| Gavilyte-C | 21 | $392 | $19 |
| Famotidine | 17 | $255 | $15 |
| Temazepam | 12 | $40 | $3 |
| Meloxicam | 12 | $17 | $1 |
2022: 17 drugs
| Linzess | 43 | $24,208 | $563 |
| Creon | 21 | $13,917 | $663 |
| Xarelto | 12 | $6,606 | $550 |
| Sucralfate | 80 | $2,187 | $27 |
| Omeprazole | 227 | $1,994 | $9 |
| Gavilyte-G | 88 | $1,221 | $14 |
| Metoprolol | 24 | $1,016 | $42 |
| Metoclopramide | 114 | $879 | $8 |
| Peg-3350 and Electrolytes | 57 | $823 | $14 |
| Famotidine | 45 | $370 | $8 |
| Clarithromycin | 12 | $348 | $29 |
| Metronidazole | 25 | $282 | $11 |
| Peg 3350-Electrolyte | 12 | $282 | $23 |
| Gavilyte-C | 12 | $192 | $16 |
| Chlorthalidone | 12 | $116 | $10 |
| Ramipril | 12 | $102 | $8 |
| Amoxicillin | 11 | $81 | $7 |
2021: 15 drugs
| Linzess | 41 | $23,026 | $562 |
| Xarelto | 16 | $8,368 | $523 |
| Omeprazole | 213 | $2,588 | $12 |
| Mesalamine | 14 | $2,472 | $177 |
| Sucralfate | 49 | $1,210 | $25 |
| Metoprolol | 24 | $1,016 | $42 |
| Metoclopramide | 82 | $763 | $9 |
| Clarithromycin | 14 | $500 | $36 |
| Peg-3350 and Electrolytes | 32 | $387 | $12 |
| Metronidazole | 20 | $278 | $14 |
| Famotidine | 23 | $250 | $11 |
| Chlorthalidone | 14 | $185 | $13 |
| Gavilyte-G | 14 | $172 | $12 |
| Amoxicillin | 16 | $113 | $7 |
| Ramipril | 12 | $113 | $9 |
2020: 16 drugs
| Linzess | 29 | $15,208 | $524 |
| Creon | 15 | $13,911 | $927 |
| Viberzi | 12 | $8,162 | $680 |
| Mesalamine | 16 | $4,780 | $299 |
| Omeprazole | 220 | $2,010 | $9 |
| Metoprolol | 24 | $1,818 | $76 |
| Sucralfate | 27 | $723 | $27 |
| Metoclopramide | 86 | $711 | $8 |
| Gavilyte-G | 59 | $685 | $12 |
| Clarithromycin | 13 | $462 | $36 |
| Chlorthalidone | 15 | $302 | $20 |
| Famotidine | 30 | $203 | $7 |
| Ramipril | 12 | $148 | $12 |
| Zolpidem | 13 | $148 | $11 |
| Metronidazole | 12 | $103 | $9 |
| Amoxicillin | 13 | $89 | $7 |
2019: 18 drugs
| Linzess | 35 | $16,776 | $479 |
| Creon | 12 | $12,148 | $1,012 |
| Omeprazole | 258 | $2,381 | $9 |
| Gavilyte-G | 91 | $1,232 | $14 |
| Esomeprazole Magnesium | 13 | $811 | $62 |
| Clarithromycin | 17 | $744 | $44 |
| Famotidine | 64 | $560 | $9 |
| Metronidazole | 31 | $455 | $15 |
| Polyethylene Glycol 3350 | 15 | $373 | $25 |
| Nifedipine Er | 13 | $365 | $28 |
| Metoclopramide | 53 | $357 | $7 |
| Peg-3350 and Electrolytes | 25 | $338 | $14 |
| Lansoprazole | 12 | $334 | $28 |
| Sucralfate | 17 | $241 | $14 |
| Peg 3350-Electrolyte | 20 | $195 | $10 |
| Amoxicillin | 16 | $148 | $9 |
| Zolpidem | 11 | $125 | $11 |
| Ranitidine | 17 | $117 | $7 |
2018: 14 drugs
| Linzess | 25 | $11,788 | $472 |
| Esomeprazole Magnesium | 33 | $5,640 | $171 |
| Omeprazole | 290 | $2,749 | $9 |
| Metronidazole | 38 | $656 | $17 |
| Gavilyte-G | 47 | $603 | $13 |
| Metoclopramide | 71 | $565 | $8 |
| Famotidine | 63 | $542 | $9 |
| Sucralfate | 27 | $392 | $15 |
| Peg-3350 and Electrolytes | 30 | $355 | $12 |
| Polyethylene Glycol 3350 | 13 | $266 | $20 |
| Amoxicillin | 24 | $227 | $9 |
| Peg 3350-Electrolyte | 19 | $192 | $10 |
| Nifedipine Er | 12 | $190 | $16 |
| Gavilyte-C | 11 | $160 | $15 |
2017: 24 drugs
| Linzess | 29 | $11,577 | $399 |
| Creon | 20 | $8,725 | $436 |
| Esomeprazole Magnesium | 29 | $5,928 | $204 |
| Janumet Xr | 11 | $4,253 | $387 |
| Nexium | 13 | $3,553 | $273 |
| Omeprazole | 333 | $3,376 | $10 |
| Metronidazole | 75 | $1,516 | $20 |
| Peg-3350 and Electrolytes | 78 | $973 | $12 |
| Gavilyte-G | 57 | $826 | $14 |
| Sucralfate | 42 | $604 | $14 |
| Famotidine | 61 | $407 | $7 |
| Amoxicillin | 44 | $369 | $8 |
| Metoclopramide | 67 | $363 | $5 |
| Polyethylene Glycol 3350 | 20 | $331 | $17 |
| Peg 3350-Electrolyte | 24 | $254 | $11 |
| Gavilyte-C | 15 | $205 | $14 |
| Propranolol | 12 | $192 | $16 |
| Pantoprazole | 15 | $132 | $9 |
| Metformin | 14 | $115 | $8 |
| Atorvastatin | 12 | $107 | $9 |
| Amlodipine Besylate | 16 | $83 | $5 |
| Glipizide | 12 | $55 | $5 |
| Metoprolol | 12 | $55 | $5 |
| Losartan-Hydrochlorothiazide | 12 | $39 | $3 |
2016: 24 drugs
| Creon | 57 | $28,089 | $493 |
| Nexium | 49 | $14,671 | $299 |
| Amitiza | 30 | $8,528 | $284 |
| Janumet Xr | 11 | $3,997 | $363 |
| Omeprazole | 328 | $3,209 | $10 |
| Metronidazole | 54 | $1,255 | $23 |
| Famotidine | 102 | $841 | $8 |
| Propranolol | 29 | $578 | $20 |
| Metoclopramide | 91 | $562 | $6 |
| Gavilyte-G | 40 | $558 | $14 |
| Peg-3350 and Electrolytes | 37 | $471 | $13 |
| Peg 3350-Electrolyte | 26 | $447 | $17 |
| Gavilyte-N | 21 | $407 | $19 |
| Sucralfate | 23 | $349 | $15 |
| Gavilyte-C | 26 | $343 | $13 |
| Amoxicillin | 27 | $311 | $12 |
| Polyethylene Glycol 3350 | 25 | $257 | $10 |
| Peg 3350-Electrolyte | 25 | $257 | $10 |
| Nifedipine Er | 12 | $192 | $16 |
| Metformin | 17 | $92 | $5 |
| Amlodipine Besylate | 14 | $43 | $3 |
| Losartan-Hydrochlorothiazide | 12 | $28 | $2 |
| Hydrochlorothiazide | 12 | $20 | $2 |
| Glipizide | 12 | $16 | $1 |
2015: 25 drugs
| Creon | 75 | $35,525 | $474 |
| Nexium | 66 | $19,580 | $297 |
| Canasa | 24 | $18,592 | $775 |
| Amitiza | 27 | $7,051 | $261 |
| Omeprazole | 294 | $4,289 | $15 |
| Janumet Xr | 11 | $3,710 | $337 |
| Suprep | 23 | $1,735 | $75 |
| Metronidazole | 69 | $1,468 | $21 |
| Famotidine | 95 | $678 | $7 |
| Metoclopramide | 83 | $666 | $8 |
| Sucralfate | 41 | $662 | $16 |
| Peg-3350 and Electrolytes | 31 | $562 | $18 |
| Gavilyte-G | 37 | $537 | $15 |
| Nifedipine Er | 12 | $298 | $25 |
| Polyethylene Glycol 3350 | 21 | $253 | $12 |
| Gavilyte-N | 12 | $233 | $19 |
| Amoxicillin | 24 | $222 | $9 |
| Propranolol | 13 | $187 | $14 |
| Peg 3350-Electrolyte | 16 | $161 | $10 |
| Ciprofloxacin | 15 | $133 | $9 |
| Losartan-Hydrochlorothiazide | 12 | $57 | $5 |
| Furosemide | 11 | $35 | $3 |
| Gabapentin | 13 | $35 | $3 |
| Amlodipine Besylate | 13 | $29 | $2 |
| Lisinopril | 11 | $25 | $2 |
2014: 17 drugs
| Creon | 41 | $17,860 | $436 |
| Nexium | 59 | $15,053 | $255 |
| Zenpep | 14 | $11,193 | $800 |
| Omeprazole | 287 | $4,028 | $14 |
| Apriso | 11 | $3,812 | $347 |
| Metronidazole | 57 | $1,312 | $23 |
| Sucralfate | 54 | $1,154 | $21 |
| Gavilyte-N | 57 | $1,092 | $19 |
| Peg-3350 | 50 | $948 | $19 |
| Famotidine | 128 | $884 | $7 |
| Metoclopramide | 50 | $375 | $8 |
| Nifedipine Er | 12 | $302 | $25 |
| Polyethylene Glycol 3350 | 13 | $226 | $17 |
| Gavilyte-C | 11 | $149 | $14 |
| Ciprofloxacin | 13 | $128 | $10 |
| Amoxicillin | 13 | $124 | $10 |
| Lisinopril | 12 | $56 | $5 |
2013: 18 drugs
| Nexium | 64 | $14,189 | $222 |
| Creon | 37 | $12,154 | $328 |
| Canasa | 13 | $8,168 | $628 |
| Omeprazole | 340 | $6,606 | $19 |
| Zenpep | 14 | $5,277 | $377 |
| Famotidine | 243 | $2,070 | $9 |
| Metronidazole | 79 | $1,875 | $24 |
| Sucralfate | 66 | $1,385 | $21 |
| Peg-3350 With Flavor Packs | 60 | $1,171 | $20 |
| Gavilyte-N | 56 | $1,129 | $20 |
| Metoclopramide | 83 | $593 | $7 |
| Nifedipine Er | 13 | $372 | $29 |
| Trilyte With Flavor Packets | 16 | $352 | $22 |
| Spironolactone | 15 | $345 | $23 |
| Amoxicillin | 22 | $266 | $12 |
| Peg 3350-Electrolyte | 22 | $259 | $12 |
| Peg-3350 and Electrolytes | 13 | $196 | $15 |
| Furosemide | 15 | $56 | $4 |
Money from drug and device companies
$239 in 2025
| 2025 | 4 | 9 | None | $239 |
| 2024 | 3 | 8 | None | $228 |
| 2023 | 5 | 9 | None | $239 |
| 2022 | 2 | 2 | None | $34 |
| 2021 | 4 | 5 | None | $113 |
| 2020 | 2 | 2 | None | $45 |
| 2019 | 3 | 5 | None | $73 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Aimmune Therapeutics | Vowst | $115 | 4 payments
|
| Boston Scientific | Overstitch Endoscopic Suturing System | $50 | 1 payment
|
| RedHill Biopharma | Talicia | $49 | 3 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $25 | 1 payment
|
See all 9 published payments
| Aimmune Therapeutics | Meals · 2025-08-05 | Vowst | $29 |
| Boston Scientific | Meals · 2025-07-31 | Overstitch Endoscopic Suturing System | $50 |
| Aimmune Therapeutics | Meals · 2025-07-07 | Vowst | $29 |
| RedHill Biopharma | Meals · 2025-05-28 | Talicia | $19 |
| RedHill Biopharma | Meals · 2025-04-23 | Talicia | $10 |
| Aimmune Therapeutics | Meals · 2025-04-02 | Zenpep | $29 |
| RedHill Biopharma | Meals · 2025-03-12 | Talicia | $20 |
| Aimmune Therapeutics | Meals · 2025-03-04 | Zenpep | $28 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-02-28 | Xifaxan | $25 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $228
| Aimmune Therapeutics | Vowst | $100 | 4 payments
|
| RedHill Biopharma | Talicia | $100 | 3 payments
|
| Abbvie | Creon | $28 | 1 payment
|
2023: $239
| Braintree Laboratories | Sutab | $80 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $65 | 4 payments
|
| Ardelyx | Ibsrela | $46 | 2 payments
|
| AbbVie | Linzess | $31 | 1 payment
|
| RedHill Biopharma | Talicia | $17 | 1 payment
|
2022: $34
| Abbvie | Linzess | $21 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $14 | 1 payment
|
2021: $113
| RedHill Biopharma | Talicia | $40 | 2 payments
|
| Amgen | Avsola | $31 | 1 payment
|
| AbbVie | Linzess | $24 | 1 payment
|
| Merck Sharp & Dohme | Dificid | $17 | 1 payment
|
2020: $45
| AbbVie | Creon | $26 | 1 payment
|
| RedHill Biopharma | Talicia | $19 | 1 payment
|
2019: $73
| Takeda Pharmaceuticals U.S.A. | Motegrity | $34 | 3 payments
|
| AbbVie | Creon | $21 | 1 payment
|
| Merck Sharp & Dohme | Dificid | $17 | 1 payment
|
Professional record
- NPI
- 1336247964
- Licence
- CA A29534California A29534: Current · expires 2028-03-31
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00A295340
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 1700 E Cesar E Chavez Ave, Suite #3700, Los Angeles, CA, 90033
- NPI first listed
- 2006-09-20
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.